272BIO SRL
5.2 FTE272BIO reported total assets of 709,601 € at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Jan 2026), with 5.2 full-time equivalents.
The score of 272BIO shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +3283 % Headcount (avg FTE) +940 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
272BIO's annual accounts
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Net result | −631,558 € | |||
| Equity | −225,308 € | |||
| Cash | 350,764 € | |||
| EBITDA | −530,781 € | |||
| Total assets | 709,601 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 12 Jan 2026
- Year ended 30 Jun 2024filed on 30 Jan 2025
- Year ended 30 Jun 2023filed on 31 Jan 2024
- Year ended 30 Jun 2022filed on 06 Feb 2023
272BIO's financial analysis
- Solvency-31.8%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of 272BIO
272BIO's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0762.638.249
- VAT number
- BE0762638249
- Peppol
- Registered · 0208:0762638249 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Jan 2021
- Registered office
- 9052 Ghent
- Size
- Micro · 5.2 FTE
- Latest accounts
- 2025 · filed on 12 Jan 2026
- Activity
- Manufacture of medicaments (NACE 21201)
272BIO (SRL) has been based in Ghent since 2021, active in: manufacture of medicaments. For 2025, it reports a net loss of 631,558 € and equity of −225,308 €; its revenue is not published. With 5.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -31.8%, below the median of its sector (47.2%).
Companies similar to 272BIO
Companies in the same business, of comparable size and area, outside its group.
- Unda Manufacture of pharmaceutical preparations Aywaille · balance sheet 517,605 €
- Phenix Property Manufacture of pharmaceutical preparations Hoogstraten · balance sheet €1.13m
- Parc Elisabeth Pharma Manufacture of pharmaceutical preparations Ganshoren · balance sheet 296,304 €
- LBS Manufacture of pharmaceutical preparations Ghent · balance sheet 291,800 €
- Mountvector Bio Manufacture of pharmaceutical preparations Ottignies-Louvain-la-Neuve · balance sheet 180,416 €
- Dr. Lins - Dr. Dubois Manufacture of basic pharmaceutical products Antwerp · balance sheet 699,515 €
- Technisch Bureau Andesco Manufacture of basic pharmaceutical products Sint-Niklaas · balance sheet 880,644 €
- Will - Pharma Manufacture of pharmaceutical preparations Wavre · balance sheet €9.73m
Frequently asked questions about 272BIO
What is the revenue of 272BIO?
272BIO files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of 272BIO?
In Belgium, the VAT number is the company number prefixed with BE: BE0762638249 for 272BIO, if the company is VAT-registered. Its company number (CBE) is 0762.638.249.
Where is the registered office of 272BIO?
According to the CBE register, the registered office of 272BIO is in 9052 Ghent.
What is the equity of 272BIO?
At the close of the 2025 financial year, the equity of 272BIO amounts to -225,308 €, a solvency of -31.8% of total assets.
How many people work at 272BIO?
5.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages 272BIO?
The register lists 4 active mandates at 272BIO. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of 272BIO
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →